We're developing novel, cost-effective endovascular therapies specifically designed for chronic venous insufficiency.
With extensive experience in interventional device manufacturing and commercialization, our seasoned team is developing next-level endovascular therapies specifically designed for chronic venous insufficiency. Crossfire is well-positioned to disrupt the endovenous market through COGS flexibility, operational excellence, and physician satisfaction.
Brady Hatcher, Founder & Principal
Brady has founded 6+ medtech start-ups, including Switchback Medical, Proto Lase, and BioSim Innovations. In addition to decades of interventional R&D experience, he’s led multiple exits including Fast Foward Medical to Vention Medical.
Scott Nelson, Founder & Principal
Scott has founded multiple medtech and healthtech start-ups including Joovv, a high-growth D2C health & wellness company that’s been featured in the New York Times, ESPN, and other well-known media outlets. Scott has 15+ years of deep vascular experience and led U.S. marketing for Medtronic’s endovenous business.
Randy Beyreis, CTO
Randy has 20+ years of deep interventional catheter design and development experience. He's co-founded and exited multiple medtech start-ups, including Fast Forward Medical to Vention Medical.
JC Sun, PhD, MBA, Advisor
JC was a core team member for Medtronic’s acquisition & integration of Invatec and has extensive cross-border medtech experience with equity financing and strategic partnerships. In addition to a PhD and MBA, JC has over 10 issued patents and has been involved in multiple product launches across the U.S., Europe, and Asia.
If you have questions about what we're working on, complete the short form below and we'll be in touch soon.
We'll respond to your message within two business days.